Evidence-based recommendations on cannabidiol (Epidyolex) for treating seizures caused by tuberous sclerosis complex.
Commercial arrangement
There is a simple discount patient access scheme for cannabidiol. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS orga...
Evidence-based recommendations on polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin and prednisolone for untreated diffuse large B-cell lymphoma in adults.
Commercial arrangement
There is a simple discount patient access scheme for polatuzumab vedotin. NHS organisations can get ...
Sandbrink, Friedhelm;
Murphy, Jennifer L;
Johansson, Melanie;
Olson, Juli L;
Edens, Ellen;
Clinton-Lont, Jamie;
Sall, James;
Spevak, Christopher;
Brown, Nicole;
Guinta, Raquel;
Macedo, Franz;
Nazario, Mitchell;
Pangarkar, Sanjog;
Preston, Samuel;
Prince, Matthew;
Real, Donna Endsley;
Riegleman, David;
Steil, Evan.
In May 2022, leadership within the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the use of opioids when managing chronic pain. This synopsis summarizes the recommendations that the authors believe are the most important to ...
Evidence-based recommendations on vutrisiran (Amvuttra) for treating hereditary transthyretin-related amyloidosis in adults.
Commercial arrangement
There is a simple discount patient access scheme for vutrisiran. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NH...
Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for regorafenib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS or...
Evidence-based recommendations on nivolumab (Opdivo) with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma.
Commercial arrangement
There is a commercial arrangement for nivolumab. NHS organisations can get...
Evidence-based recommendations on upadacitinib (Rinvoq) for treating active non-radiographic axial spondyloarthritis in adults.
Commercial arrangement
There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. N...
Evidence-based recommendations on somatrogon (Ngenla) for treating growth disturbance in children and young people aged 3 years and over....
Shi, Chen;
Fan, Bifa;
Miao, Liyan;
Chen, Xiao;
Dai, Haibin;
Xu, Ting;
Liu, Jinmei;
Luo, Min;
Yao, Difei;
Sun, Bao;
Hu, Can;
Zhao, Ming;
Zhu, Changyu;
Li, Qian;
Zhang, Yu.
Topical non-steroidal anti-inflammatory drugs (NSAIDs) are one of the primary drugs for treating musculoskeletal pain. However, there are currently no evidence-based recommendations about drug selection, drug administration, drug interactions, and use in special populations or other pharmacology-related ...
Kim, Tae-Han;
Kim, In-Ho;
Kang, Seung Joo;
Choi, Miyoung;
Kim, Baek-Hui;
Eom, Bang Wool;
Kim, Bum Jun;
Min, Byung-Hoon;
Choi, Chang In;
Shin, Cheol Min;
Tae, Chung Hyun;
Gong, Chung Sik;
Kim, Dong Jin;
Cho, Arthur Eung-Hyuck;
Gong, Eun Jeong;
Song, Geum Jong;
Im, Hyeon-Su;
Ahn, Hye Seong;
Lim, Hyun;
Kim, Hyung-Don;
Kim, Jae-Joon;
Yu, Jeong Il;
Lee, Jeong Won;
Park, Ji Yeon;
Kim, Jwa Hoon;
Song, Kyoung Doo;
Jung, Minkyu;
Jung, Mi Ran;
Son, Sang-Yong;
Park, Shin-Hoo;
Kim, Soo Jin;
Lee, Sung Hak;
Kim, Tae-Yong;
Bae, Woo Kyun;
Koom, Woong Sub;
Jee, Yeseob;
Kim, Yoo Min;
Kwak, Yoonjin;
Park, Young Suk;
Han, Hye Sook;
Nam, Su Youn;
Kong, Seong-Ho.
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group inclu...
